| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |